Search Share Prices
AZN News - AstraZeneca gets priority review in US for new NF1 treatment
The application is for the use of selumetinib in children aged three years and older. NF1 is a rare and incurable genetic condition that causes skin abnormalities and non-cancerous tumours AstraZeneca ...
AstraZeneca’s lupus drug makes up for last year’s failure, faces competition
AstraZeneca PLC’s (LON:AZN) lupus treatment reported “significant” positive data in late-stage clinical trials, in the second attempt after last year’s underwhelming results in a race with rival ...
Don't Sell AstraZeneca PLC (LON:AZN) Before You Read This
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll show how you can use AstraZeneca PLC's (LON:AZN) P/E ratio to inform your assessment of the investment ...
Premarket London: BA Parent Cuts Growth Estimates; AstraZeneca Success
IAG's passenger traffic growth slowed in October to 3.4% Pharma group AstraZeneca (LON:AZN) reported successful Phase III trials for its roxadustat drug, used to treat anemia in patients suffering ...
Latest Broker Views
Story provided by StockMarketWire.com Broker... Deutsche Bank today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 8300p (from 7800p). Story provided ...